Related Experiment Video

Updated: Oct 22, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K

Shared Molecular Mechanisms of Hypertrophic Cardiomyopathy and Its Clinical Presentations: Automated Molecular

Mila Glavaški1, Lazar Velicki1,2

  • 1Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.

Life (Basel, Switzerland)
|August 27, 2021
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) research is advanced, but molecular mechanisms remain unclear. This study identified shared molecular mechanisms underlying HCM and its diverse clinical presentations using automated data extraction.

Area of Science:

  • Cardiovascular Medicine
  • Computational Biology
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiovascular disease affecting 1 in 500 individuals.
  • Despite extensive research, the molecular underpinnings of HCM and its varied clinical manifestations are not well understood.
  • Existing research on specific HCM clinical presentations' molecular mechanisms is limited.

Purpose of the Study:

  • To investigate the shared molecular mechanisms connecting HCM and its diverse clinical presentations.
  • To leverage automated data extraction for identifying these molecular links.

Main Methods:

  • Utilized the INDRA database to aggregate pathway information and extract molecular mechanisms from scientific literature.
  • Processed data from 230,072 articles related to HCM and 19 clinical presentations.
  • Applied network analysis, including centrality scoring and noise reduction, to identify key molecular players and cooperative mechanisms.

Main Results:

  • Identified and mapped shared molecular mechanisms between HCM and its clinical presentations using network representations.
  • Determined the most significant molecular elements within intersection networks.
  • Detected cooperative molecular mechanisms underlying different HCM phenotypes.

Conclusions:

  • The identified shared molecular mechanisms offer potential insights into the pathogenesis of various HCM clinical presentations.
  • The automated methodology effectively extracted and analyzed molecular data, yielding results consistent with current scientific understanding.

Keywords:
atrial fibrillationautomated curationcardiac fibrosisdata miningheart failurehypertrophic cardiomyopathyleft ventricular outflow tract obstructionmolecular mechanismsmyocardial ischemiasudden cardiac death

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.9K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
97
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
131
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
69
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
84
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
108
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K